发明名称 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
摘要 The present invention provides pyrazole derivatives represented by the general formula: wherein R<SUP>1 </SUP>represents H, an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; one of Q and T represents a group represented by the general formula: or a group represented by the general formula: while the other represents an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; R<SUP>2 </SUP>represents H, a halogen atom, OH, an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; X represents a single bond, O or S; Y represents a single bond, a C<SUB>1-6 </SUB>alkylene group etc.; Z represents CO or SO<SUB>2</SUB>; R<SUP>4 </SUP>and R<SUP>5 </SUP>represent H, an optionally substituted C<SUB>1-6 </SUB>alkyl group etc.; and R<SUP>3</SUP>, R<SUP>6 </SUP>and R<SUP>7 </SUP>represent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.
申请公布号 US7375087(B2) 申请公布日期 2008.05.20
申请号 US20050523820 申请日期 2005.02.04
申请人 KISSEI PHARMACEUTICAL CO., LTD. 发明人 TERANISHI HIROTAKA;FUSHIMI NOBUHIKO;YONEKUBO SHIGERU;SHIMIZU KAZUO;SHIBAZAKI TOSHIHIDE;ISAJI MASAYUKI
分类号 A01N43/04;A61K31/70;A61P3/04;A61P3/06;A61P3/10;A61P9/04;A61P9/10;A61P9/12;A61P19/06;A61P43/00;C07H15/00;C07H17/02 主分类号 A01N43/04
代理机构 代理人
主权项
地址